Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Goeijenbier, Marco ^a   Van Gorp, Eric C M ^a   Van Den Brand, Judith M A ^a   Stittelaar, Koert ^b   Bakhtiari, Kamran ^c   Roelofs, Joris J T H ^c   Van Amerongen, Geert ^a   Kuiken, Thijs ^a   Martina, Byron E E ^a   Meijers, Joost C M ^c   Osterhaus, Albert D M E ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Viroclinics Biosciences BV   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Consumption coagulopathy; H1N1 subtype; H3N2 subtype; H5N1 subtype; Influenza A virus (Human)

Indexed keywords

D DIMER; FIBRIN; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CELL ACTIVATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG TISSUE LEVEL; ENDOTHELIUM CELL; EXPERIMENTAL DISEASE; FERRET; FIBRIN DEPOSITION; HEMOSTASIS; INFLUENZA VIRUS A H5N1; NONHUMAN; PANDEMIC INFLUENZA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SEASONAL INFLUENZA; VIRUS ISOLATION; VIRUS STRAIN; ANIMAL; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; COMPLICATION; CYTOCHEMISTRY; DISEASE MODEL; LUNG; MALE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; THROMBIN TIME;

ANIMALIA; AVES; HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; DISEASE MODELS, ANIMAL; FERRETS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HISTOCYTOCHEMISTRY; LUNG; MALE; ORTHOMYXOVIRIDAE INFECTIONS; PARTIAL THROMBOPLASTIN TIME; THROMBIN TIME; VON WILLEBRAND FACTOR;

EID: 84902540144     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-134     Document Type: Article

References (47)

1. Airborne transmission of influenza A/H5N1 virus between ferrets. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, De Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Science 2012 336 1534 1541 10.1126/science.1213362 22723413
2. Seasonal and pandemic influenza preparedness: a global threat. Whitley RJ, Monto AS, J Infect Dis 2006 194 Suppl 2 65 S69 17163390
3. Influenza. Nicholson KG, Wood JM, Zambon M, Lancet 2003 362 1733 1745 10.1016/S0140-6736(03)14854-4 14643124
4. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Warren-Gash C, Smeeth L, Hayward AC, Lancet Infect Dis 2009 9 601 610 10.1016/S1473-3099(09)70233-6 19778762
5. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Gurfinkel EP, Leon De La Fuente R, Mendiz O, Mautner B, Eur Heart J 2004 25 25 31 10.1016/j.ehj.2003.10.018 14683739
6. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W, Eur Heart J 2008 29 1350 1358 10.1093/eurheartj/ ehm581 18187561
7. Influenza vaccination and cardiovascular morbidity and mortality: analysis of 292,383 patients. Loomba RS, Aggarwal S, Shah PH, Arora RR, J Cardiovasc Pharmacol Ther 2012 17 277 283 10.1177/1074248411429965 22172681
8. Review: Viral infections and mechanisms of thrombosis and bleeding. Goeijenbier M, Van Wissen M, van de Weg C, Jong E, Gerdes VE, Meijers JC, Brandjes DP, van Gorp EC, J Med Virol 2012 84 1680 1696 10.1002/jmv.23354 22930518
9. Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. Berri F, Le VB, Jandrot-Perrus M, Lina B, Riteau B, Cell Mol Life Sci 2014 71 885 898 10.1007/s00018-013-1479-x 24091817
10. Mechanistic links between acute respiratory tract infections and acute coronary syndromes. Bazaz R, Marriott HM, Francis SE, Dockrell DH, J Infect 2013 66 1 17 10.1016/j.jinf.2012.09.009 23046969
11. Multiple roles of the coagulation protease cascade during virus infection. Antoniak S, Mackman N, Blood 2014 123 2605 2613 10.1182/blood-2013- 09-526277 24632711
12. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. Perez-Padilla R, De La R-Z, Ponce De Leon S, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA, INER Working Group on Influenza, N Engl J Med 2009 361 680 689 10.1056/NEJMoa0904252 19564631
13. Influenza A virus infection and pulmonary microthromboembolism. Ohrui T, Takahashi H, Ebihara S, Matsui T, Nakayama K, Sasaki H, Tohoku J Exp Med 2000 192 81 86 10.1620/tjem.192.81 11128871
14. Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1). Wang ZF, Su F, Lin XJ, Dai B, Kong LF, Zhao HW, Kang J, Thromb Res 2011 127 198 201 10.1016/j.thromres.2010.11.032 21216444
15. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Keller TT, van der Sluijs KF, De Kruif M, Gerdes VE, Meijers JC, Florquin S, van der Poll T, van Gorp EC, Brandjes DP, Büller HR, Levi M, Circ Res 2006 99 1261 1269 10.1161/01.RES.0000250834. 29108.1a 17068293
16. PAR1 contributes to influenza A virus pathogenicity in mice. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B, J Clin Invest 2013 123 206 214 10.1172/JCI61667 23202729
17. Adaptation of pandemic H1N1 influenza viruses in mice. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ, J Virol 2010 84 8607 8616 10.1128/JVI.00159-10 20592084
18. Modification of the ferret model for pneumonia from seasonal human influenza A virus infection. van den Brand JM, Stittelaar KJ, Leijten LM, Van Amerongen G, Simon JH, Osterhaus AD, Kuiken T, Vet Pathol 2012 49 562 568 10.1177/0300985811429812 22262355
19. Clinical profiles associated with influenza disease in the ferret model. Stark GV, Long JP, Ortiz DI, Gainey M, Carper BA, Feng J, Bigger JE, Vela EM, PLoS One 2013 8 58337 10.1371/journal.pone.0058337 23472182
20. The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period. Lichenstein R, Magder LS, King RE, King JC Jr, J Infect Dis 2012 206 821 827 10.1093/infdis/jis435 22798684
21. Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets. van den Brand JM, Stittelaar KJ, Van Amerongen G, Reperant L, De Wit L, Osterhaus AD, Kuiken T, PLoS One 2012 7 42343 10.1371/journal.pone.0042343 22905124
22. Procoagulant activity of endothelial cells after infection with respiratory viruses. Visseren FL, Bouwman JJ, Bouter KP, Diepersloot RJ, De Groot PH, Erkelens DW, Thromb Haemost 2000 84 319 324 10959707
23. Influenza infection and risk of acute myocardial infarction in England and Wales: a caliber self-controlled case series study. Warren-Gash C, Hayward AC, Hemingway H, Denaxas S, Thomas SL, Timmis AD, Whitaker H, Smeeth L, J Infect Dis 2012 206 1652 1659 10.1093/infdis/jis597 23048170
24. Pandemic H1N1 influenza infection and vascular thrombosis. Bunce PE, High SM, Nadjafi M, Stanley K, Liles WC, Christian MD, Clin Infect Dis 2011 52 14 e17 10.1093/cid/ciq125 21288835
25. Comparison of the blood coagulation profiles of ferrets and rats. Takahashi S, Hirai N, Shirai M, Ito K, Asai F, J Vet Med Sci 2011 73 953 956 10.1292/jvms.10-0489 21427521
26. Coagulation values in normal ferrets (Mustela putorius furo) using selected methods and reagents. Benson KG, Paul-Murphy J, Hart AP, Keuler NS, Darien BJ, Vet Clin Pathol 2008 37 286 288 10.1111/j.1939-165X.2008.00047.x 18761520
27. The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferrets. Krigsfeld GS, Sanzari JK, Kennedy AR, Int J Radiat Biol 2012 88 327 334 10.3109/09553002.2012.652727 22221163
28. An overview of the highly pathogenic H5N1 influenza virus. Yin J, Liu S, Zhu Y, Virol Sin 2013 28 3 15 10.1007/s12250-013-3294-9 23325419
29. Hemostatic disorders in bird flu infection. Wiwanitkit V, Blood Coagul Fibrinolysis 2008 19 5 6 10.1097/MBC.0b013e3282f185a6 18180608
30. Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. Berri F, Rimmelzwaan GF, Hanss M, Albina E, Foucault-Grunenwald ML, Le VB, Vogelzang-van Trierum SE, Gil P, Camerer E, Martinez D, Lina B, Lijnen R, Carmeliet P, Riteau B, PLoS Pathog 2013 9 1003229 10.1371/journal.ppat.1003229 23555246
31. Severe pandemic, H1N1 influenza disease due to pathogenic immune complexes. Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE Jr, Williams JV, Melendi GA, Polack FP, Nat Med 2009 2011 17 195 199
32. Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway. Schwartz BS, Edgington TS, J Exp Med 1981 154 892 906 10.1084/jem.154.3.892 7276829
33. Pathophysiology of disseminated intravascular coagulation in sepsis. Ten Cate H, Crit Care Med 2000 28 9 S11 10.1097/00003246-200009001-00003 11007190
34. The cardiovascular manifestations of influenza: a systematic review. Estabragh ZR, Mamas MA, Estabragh ZR, Mamas MA, Int J Cardiol 2013 10 2397 2403
35. Age distribution of cases caused by different influenza viruses. Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Lancet Infect Dis 2013 13 646 647 10.1016/S1473-3099(13)70181-6 23886322
36. Infection and inflammation as risk factors for thrombosis and atherosclerosis. Levi M, van der Poll T, Schultz M, Semin Thromb Hemost 2012 38 506 514 22399308
37. Crosstalk between inflammation and coagulation: the lessons of sepsis. van der Poll T, Levi M, Curr Vasc Pharmacol 2012 10 632 638 10.2174/ 157016112801784549 22272914
38. The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. Kale S, Yende S, Kong L, Perkins A, Kellum JA, Newman AB, Vallejo AN, Angus DC, GenIMS Investigators, PLoS One 2010 5 13852 10.1371/journal.pone.0013852 21085465
39. Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes. Pan HY, Yano M, Kido H, J Med Invest 2011 58 19 28 10.2152/jmi.58.19 21372483
40. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, Ndrade-Gordon P, Boullier S, Rousset P, Vergnolle N, Riteau B, J Immunol 2009 182 7795 7802 10.4049/jimmunol.0803743 19494303
41. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Correia LC, Sposito AC, Lima JC, Magalhaes LP, Passos LC, Rocha MS, D'Oliveira A, Esteves JP, Am J Cardiol 2003 92 298 301 10.1016/S0002-9149(03)00630-1 12888137
42. Treating influenza with statins and other immunomodulatory agents. Fedson DS, Antiviral Res 2013 99 417 435 10.1016/j.antiviral.2013.06.018 23831494
43. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Fedson DS, Clin Infect Dis 2006 43 199 205 10.1086/505116 16779747
44. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Munster VJ, De Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA, Science 2009 2009 325 481 483
45. Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Bodewes R, Kreijtz JH, Van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF, Kuiken T, Am J Pathol 2011 179 30 36 10.1016/j.ajpath.2011.03.026 21640972
46. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. Rimmelzwaan GF, Baars M, Claas EC, Osterhaus AD, J Virol Methods 1998 74 57 66 10.1016/S0166-0934(98)00071-8 9763129
47. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. van den Brand JM, Stittelaar KJ, Van Amerongen G, Rimmelzwaan GF, Simon J, De Wit E, Munster V, Bestebroer T, Fouchier RA, Kuiken T, Osterhaus AD, J Infect Dis 2010 201 993 999 10.1086/651132 20187747